Pasar al contenido principal

ALIMENTOS PARA NUTRICION PERSONALIZADA OBTENIDOS MEDIANTE PRODUCCION DE BIOACTIVOS BACTERIANOS O POR ACTIVIDAD BACTERIANA SOBRE PRODUCTOS LACTEOS: PROPIEDADES FUNCIONALES

PID2021-127362OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A shared perspective on in vitro and in vivo models to assay intestinal transepithelial transport of food compounds

  • Hevia, Arancha
  • Ruas-Madiedo, Patricia
  • Faria, Miguel Angelo
  • Petit, Valérie
  • Alves, Bruna
  • Alvito, Paula
  • Arranz, Elena
  • Bastiaan-Net, Shanna
  • Corredig, Milena
  • Dijk, Wieneke
  • Dupont, Didier
  • Giblin, Linda
  • Graf, Brigitte Anna
  • Kondrashina, Alina
  • Ramos, Helena
  • Ruíz García, Lorena
  • Santos-Hernández, Marta
  • Soriano-Romaní, Laura
  • Tomás-Cobos, Lidia
  • Vivanco-Maroto, Santiaga María
  • Recio, Isidra
  • Miralles, Beatriz
Assessing nutrient bioavailability is complex, as the process involves multiple digestion steps, several cellular environments, and regulatory-metabolic mechanisms. Several in vitro models of different physiological relevance are used to study nutrient absorption, providing significant challenges in data evaluation. However, such in vitro models are needed for mechanistic studies as well as to screen for biological functionality of the food structures designed. This collaborative work aims to put into perspective the wide-range of models to assay the permeability of food compounds considering the particular nature of the different molecules, and, where possible, in vivo data are provided for comparison., M.A.F. thanks FCT (Fundação para a Ciência e Tecnologia) for funding through program DL 57/2016 and the project DIETxPOSOME (PTDC/SAU-NUT/6061/2020). P.A. acknowledges CESAM (UIDP/50017/2020+UIDB/50017/2020+LA/P/0094/2020). Thanks are due to FCT/MCTES through national funds EarlyMyco (PTDC/MED-TOX/28762/2017). S.B.-N. acknowledges the financial support by the Dutch Ministry of Agriculture, Nature and Food Quality via the “Healthy and Safe Food System (KB-37)” knowledge base program (grand no. KB-37-001-007). P.R.-M. acknowledges the financial support to the project PID2021-127362OB-I00, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” (European Union). B.M. acknowledges the financial support by project I-link22018 financed by CSIC and PID2019-107663RB-I00 and PCD2022-133489-IOO funded by MCIN/AEI/10.13039/501100011033, the last counting with funds from EU “NextGeneration EU”/PRTR., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mouse intestinal microbiome modulation by oral administration of a GABA-producing Bifidobacterium adolescentis strain

  • Tamés, Hector
  • Sabater, Carlos
  • Royo, Félix
  • Margolles Barros, Abelardo
  • Falcón, Juan Manuel
  • Ruas-Madiedo, Patricia
  • Ruíz García, Lorena
The gut microbiome-brain communication signaling has emerged in recent years as a novel target for intervention with the potential to ameliorate some conditions associated with the central nervous system. Hence, probiotics with capacity to produce neurotransmitters, for instance, have come up as appealing alternatives to treat disorders associated with disbalanced neurotransmitters. Herein, we further deep into the effects of administering a gamma-aminobutyric acid (GABA)-producing Bifidobacterium strain, previously demonstrated to contribute to reduce serum glutamate levels, in the gut microbiome composition and metabolic activity in a mouse model. Our results demonstrate that the GABA-producing strain administration results in a specific pattern of gut microbiota modulation, different from the one observed in animals receiving non-GABA-producing strains. This opens new avenues to delineate the specific mechanisms by which IPLA60004 administration contributes to reducing serum glutamate levels and to ascertain whether this effect could exert health benefits in patients of diseases associated with high-glutamate serum concentrations., The work in our research groups was funded by the grants from the Spanish State Research Agency PID2021-127362OB-I00 (funded by MCIN/AEI/10.13039/501100011033/and by “ERDF A way of making Europe”) and Grant AYUD-2021–50910 from the autonomic Government of Principado de Asturias (FICYT, supported by FEDER). C.S. is a postdoctoral researcher supported by the Juan de la Cierva-Formación Postdoctoral Trainee Program from MICINN, the Spanish Ministry of Science and Innovation (FJC2019-042125-I). H.T. acknowledges “Severo Ochoa” predoctoral fellowship from the PCTI-Asturias., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Comparative study of the oligosaccharide profile in goat, bovine, sheep, and human milk whey

  • Urrutia-Baca, Víctor Hugo
  • Álvarez-Buylla, Jorge R.
  • Gueimonde Fernández, Miguel
  • Chuck-Hernández, Cristina
  • Ruas-Madiedo, Patricia
  • González-Iglesias, Héctor
Milk oligosaccharides are high added value compounds that could be obtained by exploiting cheese whey, a byproduct of dairy industry. The objective was to compare the abundance and diversity of oligosaccharides in whey samples from domestic animals and humans. During fresh cheese making, whey samples were collected and analyzed by untargeted and targeted small molecule analysis using high-resolution mass-spectrometry. A great similarity in the metabolite profile between goat and sheep was observed. Up to 11 oligosaccharides were observed in the sheep whey from those typically found in humans. The concentration of 2'-Fucosyllactose (0.136 ± 0.055 g/L) and 3-Fucosyllactose (0.079 ± 0.009 g/L) were significantly higher (p-value <0.01) in sheep whey, while the concentration of 3'-Sialyllactose (0.826 ± 0.638 g/L) was higher in goat whey. No significant differences were observed between goat and sheep whey for the other oligosaccharides (p-value >0.05). Therefore, sheep and goat whey could become an important source of oligosaccharides through their revalorization., The authors thank the Instituto de Productos Lácteos de Asturias (IPLA-CSIC), its Metabolomics facility (EQC2018-004633-P), the grant PID2021-127362OB-I00, and the BAMBI project (PID2021-125337OB.I00), all funded by MCIN/AEI/ 10.13039/501100011033 and by ERDF A way of making Europe, and the Healthy Food Unit (HFU) of the Institute for Obesity Research (IOR), Tecnológico de Monterrey for supporting the developing of this study. The present study was funded by the Bilateral Tecnológico de Monterrey- Consejo Superior de Investigaciones Científicas 2022 grant with reference BILTEC-22007. The authors acknowledge José María Mata for his technical support., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Biofortification of fermented foods with riboflavin-overproducing Bifidobacterium longum subsp. infantis strains

  • Tamés, Héctor
  • Cuesta, Isabel
  • Ruiz, Lorena
  • Ruas-Madiedo, Patricia
Fermented food matrices with probiotic cultures capable to enrich the content of riboflavin in the final product, and capable to deliver metabolically active strains, is an appealing alternative to prevent the issues associated with this vitamin deficiency. In this work two riboflavin-overproducing B. longum subsp. infantis strains, IPLA60015 and IPLA60012, were investigated for the elaboration of fermented drinks based on dairy and almond drink matrices. Dairy fermented products showed the highest riboflavin concentrations upon one month of refrigerated storage. The concentration of vitamin in milks fermented with a single riboflavin overproducing bifidobacterial culture, was higher than that obtained in co-culture with several yogurt starters, or that present in commercial yogurts. Besides, following simulated in vitro digestion of the biofortified products, between 59.8 and 84.6 % of the riboflavin present in the fermented foods were detected, the highest recovery occurring in the fermented dairy matrix fermented with strain IPLA60012. These results set the ground to facilitate the incorporation of novel riboflavin producing bifidobacterial cultures into fermented matrices., This work was supported by the project PID2021-127362OB-I00 (funded by MCIN/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe) and by AYUD2021-50910 from the autonomic Government of Principado de Asturias (FICYT, supported by FEDER). H. Tamés acknowledges his predoctoral “Severo Ochoa” fellowship (BP17-55) to the Regional Government of the Principado de Asturias., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Characterization of riboflavin-overproducing Bifidobacterium longum subsp. infantis strains selected by roseoflavin treatment

  • Tamés, Héctor
  • Cuesta, Isabel
  • Vázquez Sánchez, Xenia
  • López García, Paloma
  • Ruíz García, Lorena
  • Ruas-Madiedo, Patricia
Diet is the primary source of riboflavin (B2) for humans. It can also be produced by lactic acid bacteria ingested with foods and by gut microbial commensals, including some bifidobacteria. Herein an in silico analysis of potential regulatory mechanisms affecting ribD transcription and translation in Bifidobacterium longum subsp. infantis is presented. Riboflavin-overproducing strains were selected by treatment with roseoflavin of B. longum susbp. infantis CECT4551T and its spontaneous derivative IPLA60011. Whole genomes of both parental strains and the sequencing of the rib clusters of the riboflavin-overproducing ones were conducted. Punctual mutations affecting different stem-loops in the aptamer region of the FMN-riboswitch involved in the regulation of the rib expression were detected. Riboflavin overproduction of the derivative strains was confirmed through HPLC quantification in RAMc and MRSc cultures, ranging from 64.9 to 441.2 μg/L. These levels correlated to predicted secondary folding and stability of the aptamer region and/or expression platform of the rib FMN riboswitch. Safety and technological properties of the riboflavin-overproducing derivatives, in terms of antibiotic resistance profile and carbohydrate utilization capabilities, were not altered following roseoflavin exposure, thus confirming the potential aptitude of the riboflavin-overproducing derivatives to produce biofortified foods such as those formulated on dairy matrixes., This work was supported by the projects RTI2018-096339-B-I00 and PID2021-127362OB-I00 (funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”) and by AYUD2021-50910 from the autonomic Government of Principado de Asturias (FICYT, supported by FEDER). H. Tamés acknowledges his predoctoral “Severo Ochoa” fellowship (BP17-55) to the Regional Government of the Principado de Asturias and X. Vázquez acknowledges her postdoctoral research contract ITM-POSTDOC-23-05 to ISPA., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

In vitro investigation of the effects of the food additives monosodium glutamate and allura red AC on the human gut microbiota and intestinal cell lines

  • Granja-Iglesias, Adela
  • Vázquez Sánchez, Xenia
  • Sabater, Carlos
  • Hevia, Arancha
  • Garrido-Romero, Manuel
  • Muñoz Labrador, Ana
  • Galindo-Iranzo, Plácido
  • Lebrón-Aguilar, Rosa
  • Quintanilla-López, Jesús Eduardo
  • Moreno, F. Javier
  • Ruíz García, Lorena
  • Ruas-Madiedo, Patricia
This work addresses in vitro the potential impact of two food additives in the safety spotlight, i.e., the flavor enhancer monosodium glutamate (MSG) and the azo-dye colorant allura red AC (AR), on the human gut microbiota from healthy donors by using in vitro faecal batch culture models, and an intestinal cell line model. The rationale to investigate MSG and AR safety on the gut microbiota is motivated by recent research pointing to a contribution of their chronic consumption to intestinal inflammation. The short-term exposure of faecal samples to the individual additives at two single doses (0.8 and 0.08 mM for MSG; and 0.6 and 0.06 mM for AR) did not exert significant changes in the relative abundance of gut bacteria as determined through 16S rRNA sequencing. MSG and AR were degraded into γ-aminobutyric acid (GABA) and 4-amino-5-methoxy-2-methylbenzenesulfonic acid (4A5M2M), respectively, during fermentation. While GABA was exclusively derived from microbial activity, a partial degradation of AR to 4A5M2M was triggered by heat treatment of AR-containing samples prior to faecal fermentation. Further, MSG and AR alone or after exposure to faecal samples did not show cytotoxic effects on intestinal HT29 cell monolayers. These results highlight the role of the human gut bacteria and the impact of heat-based processing in the bioconversion of certain food additives. Our findings reinforce the safety of both food additives regarding their impact on the gut microbial communities under conditions resembling acute short-term exposures, although the potential biological effects of the metabolites generated from their degradation or from chronic exposures should be further investigated., This research was funded by the European Food Safety Authority (grant number GP/EFSA/ENCO/2020/02-1, and partially by MCIN/AEI/10.13039/501100011033 and ERDF/EU (projects PID2021-127362OB-I00 and PID2023-149799OB-C22) and by IDE/2024/000704. The conclusions, findings, and opinions expressed in this communicationreflect only the view of the authors and are not the official position of EFSA, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Collaborative studies on in vitro digestibility of dietary proteins based on the INFOGEST Quant protocol: toward international standardization

  • Egger, Lotti
  • Blanco-Doval, Ana
  • Sousa, Raquel
  • Abbühl, Lychou
  • Santos-Hernández, Marta
  • Miralles, Beatriz
  • Gómez-Marín, Cristina
  • Macierzanka, Adam
  • Mulet-Cabero, Ana-Isabel
  • Pérez-Moral, Natalia
  • Edwards, Cathrina
  • Fitzpatrick, Conor
  • Arranz, Elena
  • Bot, Francesca
  • O'Mahony, James A.
  • Grundy, Myriam M.-L.
  • González-González, Felipe
  • Ruas-Madiedo, Patricia
  • Ruíz García, Lorena
  • Faria, Miguel Angelo
  • Ramos, Helena
  • Jiménez-Muñoz, Luis
  • Corredig, Milena
  • Rosa-Sibakov, Natalia
  • Ménard, Olivia
  • Henry, Gwénaële
  • Olías, Raquel
  • Delgado-Andrade, Cristina
  • Simsek, Sebnem
  • Nehir El, Sedef
  • Karakaya, Sibel
  • Mes, Jurriaan
  • Ogrodowczyk, Anna M.
  • Tedeschi, Tullia
  • Dupont, Didier
  • Brodkorb, André
  • Recio, Isidra
  • Portmann, Reto
[Data availability] Data will be made available on request., L. Egger et al., Based on recommendations by the Food and Agriculture Organization, an international standardization was launched for a static in vitro protein digestibility method, recently published as the INFOGEST Quant protocol. Based on the validated INFOGEST 2.0 method, the INFOGEST Quant protocol allows quantification of total protein digestibility, individual amino acid digestibility, and digestible indispensable amino acid score (DIAAS) calculation. Comparability of protein digestibility obtained with the INFOGEST Quant method was confirmed using identical substrates in vitro and in vivo. Method standardization within the International Dairy Federation and the International Organization for Standardization was initiated, and precision data were established in two international collaborative studies by over 25 laboratories. The three applied analytical endpoints were comparable. Robust precision estimates for o-phthalaldehyde and total nitrogen showed repeatability and reproducibility limits of 10% and 15%, respectively. Moreover, the protein digestibility of fresh dairy foods was higher than in freeze-dried samples, highlighting matrix and processing effects., Isidra Recio, Beatriz Miralles, Marta Santos Hernández, and Cristina Gómez-Marin were financially supported by the grant PID2023-146542OB-I00, funded by MCIN/AEI/10.13039/501100011033. Patricia Ruas-Madiedo, Lorena Ruiz, and Felipe Gonzáles-González were financially supported by the grants PID2021-127362OB-I00 (MCIN/AEI/ 10.13039/501100011033 and ERDF “a way of making Europe”) and BP20–082 (“Severo Ochoa” grant, “Principado de Asturias” Government). Natalia Perez Moral and Cathrina Edwards were financially supported by the grant BBSRC Institute Strategic Programme Food Microbiome and Health BB/X011054/1 and its constituent project BBS/E/F/000PR13630. Sebnem Simsek, Sedef Nehir El, and Sibel Karakaya were financially supported by the Ege University Scientific Research Projects Coordination Unit with project numbers 23,214 and 29,679. Anne Rieder was financially supported by the Norwegian Fund for Research Fees for Agricultural Products (FFL) through the projects “SusHealth” and “Enable” (grant numbers 314,599 and 354,160). Miguel Ângelo Faria thanks FCT the researcher contract DOI 10.54499/CEECINSTLA/00029/2022/CP3029/CT0002. Helena Ramos thanks FCT for her Ph.D. grant (2024.01455.BD). This work received financial support from the PT national funds (FCT/MECI, Fundação para a Ciência e Tecnologia and Ministério da Educação, Ciência e Inovação) through the project UID/50006/2025 DOI 10.54499/UID/50006/2025 -Laboratório Associado para a Química Verde - Tecnologias e Processos Limpos. Clarisse Nobre and Ana C. Pinheiro were financially supported by The Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UIDB/04469/2020 unit, and by LABBELS – Associate Laboratory in Biotechnology, Bioengineering and Microelectromechanical Systems, LA/P/0029/2020. Conor Fitzpatrick and André Brodkorb were funded by the Science Foundation Ireland (SFI) and the Department of Agriculture, Food and Marine (DAFM) grant 16/RC/3835 – VistaMilk. Shannon Gwala was funded by the EAT4AGE project with funding from DAFM under the umbrella of the European Joint Program Initiative “A Healthy Diet for a Healthy Life” (JPI HDHL)., Peer reviewed